Mechanism of Hirudin-Mediated Inhibition of Proliferation in Ovarian Cancer Cells-Reference-Cited by-同舟云学术

Mechanism of Hirudin-Mediated Inhibition of Proliferation in Ovarian Cancer Cells

Published:2024-01-07 Issue: Volume: Page:
ISSN:1073-6085
Container-title:Molecular Biotechnology
language:en
Short-container-title:Mol Biotechnol

Author:

Kou Junyan,Gao Liujie,Ni Liwei,Shao Tingting,Ding Jiyuan^ORCID

Funder

Traditional Chinese Medicine Science and Technology Program Project of Zhejiang Province

Publisher

Springer Science and Business Media LLC

Subject

Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology

Link

https://link.springer.com/content/pdf/10.1007/s12033-023-01003-7.pdf

Reference34 articles.

1. Siegel, R. L., Miller, K. D., & Jemal, A. (2020). Cancer statistics, 2020. CA: A Cancer Journal for Clinicians, 70(1), 7–30.

2. Nguyen, V. H. L., Yue, C., Du, K. Y., Salem, M., O’Brien, J., & Peng, C. (2020). The role of microRNAs in epithelial ovarian cancer metastasis. International Journal of Molecular Sciences, 21(19), 7093.

3. Achen, G., Dolivet, E., Turck, M., & Fauvet, R. (2020). Incidence et impact de la maladie thrombo-embolique sur la prise en charge du cancer de l’ovaire [Incidence and impact of venous thrombosis in the diagnosis and therapeutic management of ovarian cancer]. Gynecol Obstet Fertil Senol, 48(6), 506–513.

4. Yanaranop, M. (2017). Role of hypercoagulable state for predictive ovarian malignancy in women with a pelvic mass. Journal of the Medical Association of Thailand, 100(Suppl 1), S148–S156.

5. Man, Y. N., Wang, Y. N., Hao, J., Liu, X., Liu, C., Zhu, C., & Wu, X. Z. (2015). Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism. International Journal of Gynecological Cancer, 25(1), 24–32.